| Previous Close | 177.06 |
| Open | 177.09 |
| Bid | 180.43 x 800 |
| Ask | 180.48 x 800 |
| Day's Range | 176.67 - 180.72 |
| 52 Week Range | 137.65 - 207.32 |
| Volume | |
| Avg. Volume | 5,722,375 |
| Market Cap | 319.243B |
| Beta (5Y Monthly) | 0.61 |
| PE Ratio (TTM) | 62.95 |
| EPS (TTM) | 2.87 |
| Earnings Date | Jan 31, 2025 - Feb 04, 2025 |
| Forward Dividend & Yield | 6.56 (3.70%) |
| Ex-Dividend Date | Jan 15, 2025 |
| 1y Target Est | 204.74 |
Motley Fool2 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income
Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical industry. Shares of Pfizer (NYSE: PFE) and AbbVie (NYSE: ABBV) have underperformed over the past couple of years, but these dividend payers kept raising their payouts. With dividend payouts that have risen much faster than their stock prices, shares of these three drugmakers offer yields that are way above average.
Insider MonkeyIs AbbVie Inc. (ABBV) the Best Dividend Aristocrat Stock To Buy Right Now?
We recently compiled a list of the 10 Best Dividend Aristocrat Stocks To Buy Right Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other dividend aristocrat stocks. Investors usually buy stocks with the expectation that their value will increase as the company grows more profitable. […]
